Literature DB >> 17587752

Comprehensive evaluation of genetic and environmental factors influencing the plasma lipoprotein-associated phospholipase A2 activity in a Japanese population.

Shao-Yan Zhang1, Hiroshi Shibata, Kenji Karino, Bin-You Wang, Shotai Kobayashi, Junichi Masuda, Toru Nabika.   

Abstract

The lipoprotein-associated phospholipase A2 (Lp-PLA2) metabolizes oxidized phospholipids, generating lysophosphatidylcholine. The activity of the enzyme is known to be influenced largely by a single-nucleotide polymorphism, G994T, in the Lp-PLA2 gene. Interestingly, this polymorphism is much more prevalent in Japanese than Caucasians. The purpose of the current study was to evaluate the effects of the G994T, several environmental factors, and their interactions on the Lp-PLA2 activity in a large Japanese cohort. Participants (1,110 males and 908 females) of a health-screening examination were recruited for this study. Genotyping of the G994T was done using allele-specific polymerase chain reaction (PCR). The Lp-PLA2 activity was measured using commercial kits. The minor allele (994T) frequency of the polymorphism was 0.17 in this study, which was consistent with previous reports. According to the multivariate linear regression analysis, the G994T was the most potent factor influencing the enzyme activity (standardized beta=0.76), followed by the low-density lipoprotein cholesterol (LDL-C) level (standardized beta=0.32) and the sex (standardized beta=0.13). The LDL-C level showed a significant interaction with the G994T genotype. By contrast, no significant interaction was observed between the LDL-C level and the sex. These observations should provide useful information for future clinical and epidemiological evaluations of the Lp-PLA2 activity in cardiovascular diseases in Japanese.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587752     DOI: 10.1291/hypres.30.403

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  11 in total

Review 1.  Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.

Authors:  Robert S Rosenson; Diana M Stafforini
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

2.  Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL-cholesterol concentration in baboons fed an atherogenic diet.

Authors:  Amanda Vinson; Michael C Mahaney; Vince P Diego; Laura A Cox; Jeffrey Rogers; John L VandeBerg; David L Rainwater
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 3.  The role of lipoprotein-associated phospholipase a₂ as a marker and potential therapeutic target in atherosclerosis.

Authors:  Ralph A H Stewart; Harvey D White
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

4.  Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study.

Authors:  Renate Schnabel; Josée Dupuis; Martin G Larson; Kathryn L Lunetta; Sander J Robins; Yanyan Zhu; Jian Rong; Xiaoyan Yin; Heide A Stirnadel; Jeanne J Nelson; Peter W F Wilson; John F Keaney; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Atherosclerosis       Date:  2008-11-05       Impact factor: 5.162

5.  Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study.

Authors:  Liping Hou; Shufeng Chen; Hongjiang Yu; Xiangfeng Lu; Jianhong Chen; Laiyuan Wang; Jianfeng Huang; Zhongjie Fan; Dongfeng Gu
Journal:  Hum Genet       Date:  2008-11-26       Impact factor: 4.132

6.  Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.

Authors:  Ida J Hatoum; Jeanenne J Nelson; Nancy R Cook; Frank B Hu; Eric B Rimm
Journal:  Am J Clin Nutr       Date:  2010-01-27       Impact factor: 7.045

7.  Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males.

Authors:  Yangsoo Jang; Dawn Waterworth; Jong-Eun Lee; Kijoung Song; Sujin Kim; Hyo-Soo Kim; Kyung Woo Park; Hyun-Jai Cho; Il-Young Oh; Jeong Euy Park; Bok-Soo Lee; Hyo Jeong Ku; Dong-Jik Shin; Jong Ho Lee; Sun Ha Jee; Bok-Ghee Han; Hye-Yoon Jang; Eun-Young Cho; Patrick Vallance; John Whittaker; Lon Cardon; Vincent Mooser
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

8.  Racial variation in lipoprotein-associated phospholipase A₂ in older adults.

Authors:  Keane K Lee; Stephen P Fortmann; Ann Varady; Joan M Fair; Alan S Go; Thomas Quertermous; Mark A Hlatky; Carlos Iribarren
Journal:  BMC Cardiovasc Disord       Date:  2011-06-29       Impact factor: 2.298

9.  A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass.

Authors:  Yue Qi; Dong Zhao; Zhangrong Jia; Wei Wang; Miao Wang; Jiayi Sun; Jun Liu; Yan Li; Wuxiang Xie; Jing Liu
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

10.  A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults.

Authors:  Iona Y Millwood; Derrick A Bennett; Robin G Walters; Robert Clarke; Dawn Waterworth; Toby Johnson; Yiping Chen; Ling Yang; Yu Guo; Zheng Bian; Alex Hacker; Astrid Yeo; Sarah Parish; Michael R Hill; Stephanie Chissoe; Richard Peto; Lon Cardon; Rory Collins; Liming Li; Zhengming Chen
Journal:  Int J Epidemiol       Date:  2016-06-14       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.